Report cover image

Digital Transformation Market Share, Size, Trends, Industry Analysis Report, By Type; By Deployment (Hosted, On-premise); By Enterprise Size; By End-Use (BFSI, Government, Healthcare, IT & Telecom, Manufacturing, Retail, Others); By Region; Segment Foreca

Publisher Polaris Market Research & Consulting LLP
Published Sep 01, 2025
Length 112 Pages
SKU # PLRS20470302

Description

The global digital transformation market size is expected to reach USD 12.72 trillion by 2034, according to a new study by Polaris Market Research. The report “Digital Transformation Market Share, Size, Trends, Industry Analysis Report, By Type, By Deployment (Hosted, On-premise), By Enterprise Size, By End Use, and By Region -Market Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is growing at a notable rate due to the fast expansion of the Internet of Things (IoT) industry and the rising acceptance of cloud-based services. Furthermore, the emergence of the 4.0 industry necessitates using digital transformation technologies to improve organizational efficiency and productivity while maximizing consumer experience contributing to industrial success.

Based on deployment, the on-premises segment held the largest revenue share, as it facilitates high-end data security and easy compliance with numerous government policies. The hosted segment is likely to rise at a healthy rate in the foreseen years due to increasing advancements in the IT sector and the penetration of smartphones. Moreover, the segment provides cost-effectiveness and flexibility and allows large-scale customization of goods & services.

The shifting consumer preferences and increasing operation proficiencies in the organizations lead to the growing demand for digitalizing business functions to drive the industry’s growth. The adoption of evolving technologies such as big data & analytics, IoT, cloud, social media, and mobility has led to the advancements and transformation of the industries, which leads to the growth of the business ecosystem.

Industry participants such as Adobe, Accenture, Alcor Solutions, Inc., Broadcom, Inc, Apple, Inc., CA Technologies, Dell Technologies Inc., Cognizant, Equinix, Inc., HCL Technologies, Google, Inc., TIBCO Software Inc., Hewlett Packard Enterprise, International Business Machines Corp., Interfacing, KELLTON TECH, Microsoft Corp, Marlabs, Oracle Corporation, Smartstream, SAP Company, and Yash Technologies are some of the key players operating in the global market.

Polaris market research has segmented the digital transformation market report on the basis of type, deployment, enterprise size, end use, and region:

Digital Transformation, Type Outlook (Revenue - USD Trillion, 2020 - 2034)

Solution

Analytics

Cloud Computing

Mobility

Social Media

Others

Service

Professional Services

Implementation & Integration

Digital Transformation, Deployment Outlook (Revenue - USD Trillion, 2020 - 2034)

Hosted

On-premise

Digital Transformation, Enterprise Size Outlook (Revenue - USD Trillion, 2020 - 2034)

Large Enterprise

Small & Medium Enterprise

Digital Transformation, End-Use Outlook (Revenue - USD Trillion, 2020 - 2034)

BFSI

Government

Healthcare

IT & Telecom

Manufacturing

Retail

Others

Digital Transformation, Regional Outlook (Revenue - USD Trillion, 2020 - 2034)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Netherlands

Russia

Spain

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

112 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Retail and E-Commerce
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Immunoassay Market Insights
4.1. U.S. Immunoassay Market – Material Snapshot
4.2. U.S. Immunoassay Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing Prevalence of Chronic and Infectious Diseases
4.2.1.2. Technological Advancements in Immunoassay Methods
4.2.2. Restraints and Challenges
4.2.2.1. Regulatory Challenges and Market Fragmentation
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Immunoassay Market Material Trends
4.6. Value Chain Analysis
5. U.S. Immunoassay Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Immunoassay Market, by Product, 2020-2034 (USD Billion)
5.3. Reagents & Kits
5.3.1. U.S. Immunoassay Market, by Reagents & Kits, 2020–2034 (USD Billion)
5.3.2. ELISA Reagents & Kits
5.3.2.1. U.S. Immunoassay Market, by ELISA Reagents & Kits, 2020–2034 (USD Billion)
5.3.3. Rapid Test Reagents & Kits
5.3.3.1. U.S. Immunoassay Market, by Rapid Test Reagents & Kits, 2020–2034 (USD Billion)
5.3.4. Western Blot Reagents & Kits
5.3.5. U.S. Immunoassay Market, by Western Blot Reagents & Kits, 2020–2034 (USD Billion)
5.3.6. ELISPOT Reagents & Kits
5.3.6.1. U.S. Immunoassay Market, by ELISPOT Reagents & Kits, 2020–2034 (USD Billion)
5.3.7. Other Reagents & Kits
5.3.7.1. U.S. Immunoassay Market, by Other Reagents & Kits, 2020–2034 (USD Billion)
5.4. Analyzers/Instruments
5.4.1. U.S. Immunoassay Market, by Analyzers/ Instruments, 2020–2034 (USD Billion)
5.4.2. Open Ended Systems
5.4.2.1. U.S. Immunoassay Market, by Open Ended Systems, 2020–2034 (USD Billion)
5.4.3. Closed Ended Systems
5.4.3.1. U.S. Immunoassay Market, by Closed Ended Systems, 2020–2034 (USD Billion)
5.5. Software & Services
5.5.1. U.S. Immunoassay Market, by Software & Services, 2020–2034 (USD Billion)
6. U.S. Immunoassay Market, Technology
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Immunoassay Market, Technology, 2020-2034 (USD Billion)
6.3. Enzyme Immunoassays (EIA)
6.3.1. U.S. Immunoassay Market, by Enzyme Immunoassays (EIA), 2020–2034 (USD Billion)
6.3.2. Chemiluminescence Immunoassays (CLIA)
6.3.2.1. U.S. Immunoassay Market, by Chemiluminescence Immunoassays (CLIA), 2020–2034 (USD Billion)
6.3.3. Fluorescence Immunoassays (FIA)
6.3.3.1. U.S. Immunoassay Market, by Fluorescence Immunoassays (FIA), 2020–2034 (USD Billion)
6.4. Rapid Test
6.4.1. U.S. Immunoassay Market, by Rapid Test, 2020–2034 (USD Billion)
6.5. Radioimmunoassay (RIA)
6.5.1. U.S. Immunoassay Market, by Radioimmunoassay (RIA), 2020–2034 (USD Billion)
6.6. Others
6.6.1. U.S. Immunoassay Market, by Others, 2020–2034 (USD Billion)
7. U.S. Immunoassay Market, by Specimen
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Immunoassay Market, by Specimen, 2020-2034 (USD Billion)
7.3. Blood
7.3.1. U.S. Immunoassay Market, by Blood, 2020–2034 (USD Billion)
7.4. Urine
7.4.1. U.S. Immunoassay Market, by Urine, 2020–2034 (USD Billion)
7.5. Saliva
7.5.1. U.S. Immunoassay Market, by Saliva, 2020–2034 (USD Billion)
7.6. Others
7.6.1. U.S. Immunoassay Market, by Others, 2020–2034 (USD Billion)
8. U.S. Immunoassay Market, by Application
8.1. Key Findings
8.2. Introduction
8.2.1. U.S. Immunoassay Market, by Application, 2020-2034 (USD Billion)
8.3. Infectious Disease Testing
8.3.1. U.S. Immunoassay Market, by Infectious Disease Testing, 2020–2034 (USD Billion)
8.4. Cardiology
8.4.1. U.S. Immunoassay Market, by Cardiology, 2020–2034 (USD Billion)
8.5. Oncology
8.5.1. U.S. Immunoassay Market, by Oncology, 2020–2034 (USD Billion)
8.6. Endocrinology
8.6.1. U.S. Immunoassay Market, by Endocrinology, 2020–2034 (USD Billion)
8.7. Autoimmune Diseases
8.7.1. U.S. Immunoassay Market, by Autoimmune Diseases, 2020–2034 (USD Billion)
8.8. Therapeutic Drug Monitoring
8.8.1. U.S. Immunoassay Market, by Therapeutic Drug Monitoring, 2020–2034 (USD Billion)
8.9. Others
8.9.1. U.S. Immunoassay Market, by Others, 2020–2034 (USD Billion)
9. U.S. Immunoassay Market, by End Use
9.1. Key Findings
9.2. Introduction
9.2.1. U.S. Immunoassay Market, by End Use, 2020-2034 (USD Billion)
9.3. Hospitals
9.3.1. U.S. Immunoassay Market, by Hospitals, 2020-2034 (USD Billion)
9.4. Laboratories
9.4.1. U.S. Immunoassay Market, by Laboratories, 2020-2034 (USD Billion)
9.5. Others
9.5.1. U.S. Immunoassay Market, by Others, 2020-2034 (USD Billion)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Abbott
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Agilent Technologies, Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. BD
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. Beckman Coulter, Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. Bio-Rad Laboratories, Inc.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. DH Life Sciences, LLC.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Dynex Technologies, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. Quanterix
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. QuidelOrtho Corporation
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. Thermo Fisher Scientific Inc.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us